Art. 36 Directive (EU) 2001/83

In forcecited 6×
1.

Where a Member State considers that the variation of a marketing authorization which has been granted in accordance with the provisions of this Chapter or its suspension or withdrawal is necessary for the protection of public health, the Member State concerned shall forthwith refer the matter to the Agency for the application of the procedures laid down in Articles 32, 33 and 34.

2.

Without prejudice to the provisions of Article 31, in exceptional cases, where urgent action is essential to protect public health, until a definitive decision is adopted a Member State may suspend the marketing and the use of the medicinal product concerned on its territory. It shall inform the Commission and the other Member States no later than the following working day of the reasons for its action.

  • Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006. Merck Sharp & Dohme Ltd and Others v Commission of the European Decision

    Chapter 4 (‘Mutual recognition of authorisations’) of Title III HUM (‘Placing on the market’) contains the following provisions: ‘Article 27 [corresponding to Article 8 of Directive 75/319, as amended]: In order to facilitate the …

    31 Jan 2006 · 62003TJ0273

  • Code de la santé publiquer5121-41-7Law

    … nécessaire de la mettre en conformité avec une décision de la Commission européenne saisie dans le cadre des articles 30, 31 et 36 de la directive 2001/83/ CE du 6 novembre 2001 instituant un code communautaire relatif aux médicaments …

  • Directive (EU) 2010/84Lawamends

  • Opinion of Mr Advocate General Bot delivered on 10 July 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DeparDecision

    Directive 2001/83 then includes a Chapter 4, entitled ‘Mutual recognition of authorisations’. This chapter, which encompasses Articles 27 to 39, occupies a central place in these preliminary reference proceedings.

    10 Jul 2008 · 62006CC0452

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 1 December 2016. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision

    I recall, moreover, that such medicinal products come under Directive 2001/83 and, accordingly, under the rules of free movement based on mutual recognition of marketing authorisations as provided for in Articles 28 to 39 of that …

    1 Dec 2016 · 62015CC0296

  • Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006. Albert Albrecht GmbH & Co. KG and Others v Commission of the EurDecision

    31 Jan 2006 · 62003TJ0251